Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. H2 Relaxin, Human
2. Relaxin 2 Protein, Human
3. Relaxin H2, Human
4. Relaxin-2 Protein, Human
5. Rln2 Protein, Human
6. Rlx2 Protein, Human
1. 99489-94-8
2. Human Relaxin 2
3. Human Relaxin Ii
4. Relexan 2
5. H2 Relaxin, Human
6. Relaxin H2, Human
7. Relaxin Ii (human)
8. Serelaxin [usan:inn]
9. Relaxin-2 Protein, Human
10. Rlx030
11. Human Relaxin 2 (relaxin H2)
12. Unii-w0122b976y
13. Dtxsid40244082
14. Rlx 030
15. W0122b976y
| Molecular Weight | 5963 g/mol |
|---|---|
| Molecular Formula | C256H408N74O74S8 |
| XLogP3 | -19.3 |
| Hydrogen Bond Donor Count | 87 |
| Hydrogen Bond Acceptor Count | 91 |
| Rotatable Bond Count | 194 |
| Exact Mass | 5960.8270502 g/mol |
| Monoisotopic Mass | 5958.8203405 g/mol |
| Topological Polar Surface Area | 2600 Ų |
| Heavy Atom Count | 412 |
| Formal Charge | 0 |
| Complexity | 14800 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 55 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Investigated for use/treatment in cardiovascular disorders, congestive heart failure, infertility, peripheral vascular disease, and scleroderma.
Treatment of acute heart failure
Treatment of acute heart failure
C01DX21
C - Cardiovascular system
C01 - Cardiac therapy
C01D - Vasodilators used in cardiac diseases
C01DX - Other vasodilators used in cardiac diseases
C01DX21 - Serelaxin
Recombinant human relaxin inhibits contractions of the uterus and may play a role in timing of delivery. Relaxin works by simultaneously cutting collagen production and increasing collagen breakdown.
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ABOUT THIS PAGE
A Relaxin-2 protein, human manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Relaxin-2 protein, human, including repackagers and relabelers. The FDA regulates Relaxin-2 protein, human manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Relaxin-2 protein, human API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Relaxin-2 protein, human supplier is an individual or a company that provides Relaxin-2 protein, human active pharmaceutical ingredient (API) or Relaxin-2 protein, human finished formulations upon request. The Relaxin-2 protein, human suppliers may include Relaxin-2 protein, human API manufacturers, exporters, distributors and traders.
Relaxin-2 protein, human Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Relaxin-2 protein, human GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Relaxin-2 protein, human GMP manufacturer or Relaxin-2 protein, human GMP API supplier for your needs.
A Relaxin-2 protein, human CoA (Certificate of Analysis) is a formal document that attests to Relaxin-2 protein, human's compliance with Relaxin-2 protein, human specifications and serves as a tool for batch-level quality control.
Relaxin-2 protein, human CoA mostly includes findings from lab analyses of a specific batch. For each Relaxin-2 protein, human CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Relaxin-2 protein, human may be tested according to a variety of international standards, such as European Pharmacopoeia (Relaxin-2 protein, human EP), Relaxin-2 protein, human JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Relaxin-2 protein, human USP).
LOOKING FOR A SUPPLIER?
